Peak6 Investments LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$460.0 - $505.78 $46,000 - $50,578
100 Added 1.27%
8,000 $3.72 Million
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $3.1 Million - $3.84 Million
7,900 New
7,900 $3.7 Million
Q4 2023

Feb 13, 2024
BUY
$343.0 - $410.68 $960,400 - $1.15 Million
2,800 Added 147.37%
4,700 $1.91 Million
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $101,454 - $108,738
-300 Reduced 13.64%
1,900 $660,000
Q2 2023

Aug 11, 2023
SELL
$314.42 - $351.91 $7.04 Million - $7.88 Million
-22,400 Reduced 91.06%
2,200 $774,000
Q1 2023

May 12, 2023
BUY
$283.23 - $323.1 $4.59 Million - $5.23 Million
16,200 Added 192.86%
24,600 $7.75 Million
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $1.54 Million - $1.74 Million
-5,400 Reduced 39.13%
8,400 $2.43 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $12.5 Million - $14 Million
-45,700 Reduced 76.81%
13,800 $4 Million
Q2 2022

Aug 12, 2022
BUY
$234.96 - $292.55 $13.9 Million - $17.3 Million
59,200 Added 19733.33%
59,500 $16.8 Million
Q1 2022

May 13, 2022
SELL
$221.42 - $260.97 $3.21 Million - $3.78 Million
-14,500 Reduced 97.97%
300 $78,000
Q3 2021

Nov 12, 2021
SELL
$181.39 - $202.99 $36 Million - $40.3 Million
-198,400 Reduced 93.06%
14,800 $2.69 Million
Q2 2021

Aug 13, 2021
BUY
$187.49 - $221.1 $31.9 Million - $37.7 Million
170,300 Added 396.97%
213,200 $43 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $1.97 Million - $2.29 Million
9,500 Added 28.44%
42,900 $9.22 Million
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $1.39 Million - $1.85 Million
6,700 Added 25.09%
33,400 $7.89 Million
Q3 2020

Nov 13, 2020
SELL
$255.65 - $303.1 $4.55 Million - $5.4 Million
-17,800 Reduced 40.0%
26,700 $7.27 Million
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $7.22 Million - $9.47 Million
-32,000 Reduced 41.83%
44,500 $12.9 Million
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $12.1 Million - $15.1 Million
60,800 Added 387.26%
76,500 $18.2 Million
Q4 2019

Feb 13, 2020
SELL
$166.71 - $223.91 $7.95 Million - $10.7 Million
-47,700 Reduced 75.24%
15,700 $3.44 Million
Q3 2019

Nov 08, 2019
SELL
$166.23 - $187.09 $5.3 Million - $5.97 Million
-31,900 Reduced 33.47%
63,400 $10.7 Million
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $4.61 Million - $5.33 Million
28,000 Added 41.6%
95,300 $17.5 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $6.04 Million - $7.18 Million
-36,900 Reduced 35.41%
67,300 $12.4 Million
Q4 2018

Feb 13, 2019
BUY
$151.91 - $192.21 $2.08 Million - $2.63 Million
13,700 Added 15.14%
104,200 $17.3 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $15.2 Million - $17.4 Million
90,500 New
90,500 $17.4 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email